The CXCL12/CXCR4/ACKR3 Response Axis in Chronic Neurodegenerative Disorders of the Central Nervous System: Therapeutic Target and Biomarker

被引：7
|
作者：
Yan, Yudie [1 ]
Su, Jingtong [2 ]
Zhang, Zhen [1 ]
机构：
[1] China Med Univ, Affiliated Hosp 1, Dept Ultrasound, Shenyang 110001, Liaoning, Peoples R China
[2] Jinzhou Med Univ, Jinzhou City, Liaoning, Peoples R China
来源：
CELLULAR AND MOLECULAR NEUROBIOLOGY | 2022年 / 42卷 / 07期
基金：
中国国家自然科学基金;
关键词：
ACKR3; CXCL12; CXCR4; Neurodegenerative disorders; Central nervous system; ALZHEIMERS-DISEASE; CXCL12; EXPRESSION; CHEMOKINE CXCL12; MICROGLIA; MIGRATION; RECEPTOR; CELLS; MODEL; GLYCOSAMINOGLYCANS; DEFICIENT;
D O I：
10.1007/s10571-021-01115-1
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
There has been an increase in the incidence of chronic neurodegenerative disorders of the central nervous system, including Alzheimer's and Parkinson's diseases, over the recent years mostly due to the rise in the number of elderly individuals. In addition, various neurodegenerative disorders are related to imbalances in the CXCL12/CXCR4/ACKR3 response axis. Notably, the CXC Chemokine Ligand 12 (CXCL12) is essential for the development of the central nervous system. Moreover, the expression and distribution of CXCL12 and its receptors are associated with the aggravation or alleviation of symptoms of neurodegenerative disorders. Therefore, the current review sought to highlight the specific functions of CXCL12 and its receptors in various neurodegenerative disorders, in order to provide new insights for future research.
引用
收藏
页码：2147 / 2156
页数：10
相关论文
共 50 条
  • [41] Differential beta-3 integrin of CXCR3, CXCR4, and CXCR7 clustering on breast cancer cells in response to CXCL11, CXCL12, and Adrenomedullin
    Mosley, LaSharon Denise
    Sharma, Praveen K.
    Singh, Rajesh
    Singh, Shailesh
    Lillard, James W., Jr.
    FASEB JOURNAL, 2008, 22
  • [42] JMJD3 promotes the epithelial-mesenchymal transition and migration of glioma cells via the CXCL12/CXCR4 axis
    Zou, Shuang
    Zhang, Dongchen
    Xu, Zhongwei
    Wen, Xiaochang
    Zhang, Yan
    ONCOLOGY LETTERS, 2019, 18 (06) : 5930 - 5940
  • [43] CXCL12/CXCR4 Axis-Targeted Dual-Functional Nano-Drug Delivery System Against Ovarian Cancer
    Xue, Jiyang
    Li, Ruixiang
    Gao, Dingding
    Chen, Fenghua
    Xie, Hongjuan
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2020, 15 : 5701 - 5718
  • [44] FIG ligand and the Flt3 receptor regulate hematopoietic cell migration by modulating the SDF-1α(CXCL12)/CXCR4 axis
    Fukuda, S
    Broxmeyer, HE
    Pelus, LM
    BLOOD, 2005, 105 (08) : 3117 - 3126
  • [45] CXCL12/CXCR4 axis confers adriamycin resistance to human chronic myelogenous leukemia and oroxylin A improves the sensitivity of K562/ADM cells
    Wang, Yu
    Miao, Hanchi
    Li, Wei
    Yao, Jing
    Sun, Yang
    Li, Zhiyu
    Zhao, Li
    Guo, Qinglong
    BIOCHEMICAL PHARMACOLOGY, 2014, 90 (03) : 212 - 225
  • [46] Internal Tandem Duplication Mutations in FLT3 Gene Augment Chernotaxis to Cxcl12 Protein by Blocking the Down-regulation of the Rho-associated Kinase via the Cxcl12/Cxcr4 Signaling Axis
    Onish, Chie
    Mori-Kimachi, Satomi
    Hirade, Tomohiro
    Abe, Mariko
    Taketani, Takeshi
    Suzumiya, Junji
    Sugimoto, Toshitsugu
    Yamaguchi, Seiji
    Kapur, Reuben
    Fukuda, Seiji
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2014, 289 (45) : 31053 - 31065
  • [47] Identification of the CXCL12-CXCR4/CXCR7 axis as a potential therapeutic target for immunomodulating macrophage polarization and foreign body response to Implanted biomaterials
    Cai, Xinjie
    Chen, Ruiying
    Ma, Kena
    Wang, Fushi
    Zhou, Yi
    Wang, Yining
    Jiang, Tao
    APPLIED MATERIALS TODAY, 2020, 18
  • [48] Paper lncRNA MEG3 aggravated neuropathic pain and astrocyte overaction through mediating miR-130a-5p/CXCL12/CXCR4 axis
    Dong, Jiacai
    Xia, Rui
    Zhang, Zhonggui
    Xu, Cheng
    AGING-US, 2021, 13 (19): : 23004 - 23019
  • [49] The Flt3 ligand/Flt3 axis regulates migration of normal and transformed hematopoietic cells by modulating SDF1α (CXCL12)/CXCR4 signaling.
    Fukuda, S
    Broxmeyer, HE
    Pelus, LM
    BLOOD, 2003, 102 (11) : 350A - 350A
  • [50] Bone marrow mesenchymal stromal cells non-selectively protect chronic myeloid leukemia cells from imatinib-induced apoptosis via the CXCR4/CXCL12 axis
    Vianello, Fabrizio
    Villanova, Federica
    Tisato, Veronica
    Lymperi, Stefania
    Ho, Ka-Kei
    Gomes, Ana R.
    Marin, David
    Bonnet, Dominique
    Apperley, Jane
    Lam, Eric W. -F.
    Dazzi, Francesco
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 (07): : 1081 - 1089
12345